LU86949A1 - Acides hydroximiques d'ethers et de thioethers 7-oxabicycloheptane substitues - Google Patents

Acides hydroximiques d'ethers et de thioethers 7-oxabicycloheptane substitues Download PDF

Info

Publication number
LU86949A1
LU86949A1 LU86949A LU86949A LU86949A1 LU 86949 A1 LU86949 A1 LU 86949A1 LU 86949 A LU86949 A LU 86949A LU 86949 A LU86949 A LU 86949A LU 86949 A1 LU86949 A1 LU 86949A1
Authority
LU
Luxembourg
Prior art keywords
group
compound
acid
ester
oxabicyclo
Prior art date
Application number
LU86949A
Other languages
English (en)
French (fr)
Inventor
Eric Michael Gordon
Ravi Kannadikovilakom Varma
Ligaya Magbanua Simpkins
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of LU86949A1 publication Critical patent/LU86949A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
LU86949A 1986-07-23 1987-07-22 Acides hydroximiques d'ethers et de thioethers 7-oxabicycloheptane substitues LU86949A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88867186 1986-07-23
US06/888,671 US4673685A (en) 1986-07-23 1986-07-23 Hydroximic acids of 7-oxabicycloheptane substituted ethers and thioethers useful in the treatment of thrombotic disease

Publications (1)

Publication Number Publication Date
LU86949A1 true LU86949A1 (fr) 1988-02-02

Family

ID=25393633

Family Applications (1)

Application Number Title Priority Date Filing Date
LU86949A LU86949A1 (fr) 1986-07-23 1987-07-22 Acides hydroximiques d'ethers et de thioethers 7-oxabicycloheptane substitues

Country Status (29)

Country Link
US (1) US4673685A (ja)
JP (1) JP2557894B2 (ja)
KR (1) KR950010596B1 (ja)
AT (1) AT397094B (ja)
AU (1) AU599384B2 (ja)
BE (1) BE1000141A3 (ja)
CA (1) CA1292003C (ja)
CH (1) CH674010A5 (ja)
DD (1) DD263990A5 (ja)
DE (1) DE3724152A1 (ja)
DK (1) DK383587A (ja)
ES (1) ES2006784A6 (ja)
FI (1) FI873207A (ja)
FR (1) FR2601953B1 (ja)
GB (1) GB2192882B (ja)
GR (1) GR871147B (ja)
HU (1) HU198495B (ja)
IE (1) IE60487B1 (ja)
IL (1) IL82919A0 (ja)
IT (1) IT1222054B (ja)
LU (1) LU86949A1 (ja)
NL (1) NL8701742A (ja)
NO (1) NO168359C (ja)
NZ (1) NZ220677A (ja)
PH (1) PH23711A (ja)
PT (1) PT85381B (ja)
SE (1) SE8702936L (ja)
YU (1) YU46321B (ja)
ZA (1) ZA874255B (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8501035D0 (en) * 1985-01-16 1985-02-20 Senior J Prostaglandins
AU593316B2 (en) * 1986-02-14 1990-02-08 E.R. Squibb & Sons, Inc. Hydroxamic acids of 7-oxabicycloheptane substituted ethers
US4673685A (en) * 1986-07-23 1987-06-16 E. R. Squibb & Sons, Inc. Hydroximic acids of 7-oxabicycloheptane substituted ethers and thioethers useful in the treatment of thrombotic disease
US4925873A (en) * 1988-09-01 1990-05-15 E. R. Squibb & Sons, Inc. Method of treating skin injuries using thromboxane A2 receptor antagonists
US5093329A (en) * 1990-03-12 1992-03-03 Allergan, Inc. Intraocular pressure reducing prostaglandin-like 7-oxabicyclo derivatives

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4242273A (en) * 1977-09-27 1980-12-30 American Cyanamid Company 4-(Monoalkylamino)benzoic acid amides and imidates
US4187236A (en) * 1977-11-04 1980-02-05 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane compounds
US4254044A (en) * 1977-11-04 1981-03-03 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane- and 7-oxabicycloheptene compounds
US4220594A (en) * 1977-11-04 1980-09-02 E. R. Squibb & Sons, Inc. Hexa- and octahydro-4,7-epoxyisobenzofuran-1-ol and hexa- and octahydro-5,8-epoxy-1H-2-benzopyran-3-ol
US4143054A (en) * 1977-11-04 1979-03-06 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane- and 7-oxabicycloheptene compounds
WO1980001381A1 (en) * 1979-01-05 1980-07-10 R Jones Substituted bicyclo (2,2,1) heptanes and hept-2-enes
US4440940A (en) * 1979-10-17 1984-04-03 American Cyanamid Company Anti-atherosclerotic agents
US4228180A (en) * 1979-11-01 1980-10-14 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane and 7-oxabicycloheptene prostaglandin analogs
ZA814307B (en) * 1980-07-01 1983-02-23 Nat Res Dev Prostaglandins
WO1983002273A1 (en) * 1981-12-23 1983-07-07 Jones, Robert, Leslie Prostaglandins
US4466979A (en) * 1983-01-21 1984-08-21 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane substituted carbamate prostaglandin analogs useful in treating platelet aggregation and bronchoconstriction
CA1256887A (en) * 1983-03-14 1989-07-04 Steven E. Hall 7-oxabicycloheptane substituted prostaglandin analogs
US4474803A (en) * 1983-03-14 1984-10-02 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane substituted thio prostaglandin analogs useful in treating platelet aggregation and bronchoconstriction
US4513103A (en) * 1983-10-21 1985-04-23 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane ethers useful in the treatment of thrombolytic disease
US4526901A (en) * 1984-01-26 1985-07-02 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane substituted oxamide prostaglandin analogs and their use in treating thrombolytic disease
US4536513A (en) * 1984-03-14 1985-08-20 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane substituted prostaglandin interphenylene analogs useful in the treatment of thrombolytic disease
US4661506A (en) * 1984-11-30 1987-04-28 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane substituted ox prostaglandin analogs
US4654367A (en) * 1986-02-14 1987-03-31 E. R. Squibb & Sons, Inc. Hydroxamic acids of 7-oxabicycloheptane substituted ethers useful as anti-allergy and anti-inflammation agents
US4652578A (en) * 1986-02-24 1987-03-24 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane substituted amide prostaglandin analogs
US4673685A (en) * 1986-07-23 1987-06-16 E. R. Squibb & Sons, Inc. Hydroximic acids of 7-oxabicycloheptane substituted ethers and thioethers useful in the treatment of thrombotic disease

Also Published As

Publication number Publication date
NO168359C (no) 1992-02-12
SE8702936L (sv) 1988-04-07
NL8701742A (nl) 1988-02-16
AU7444887A (en) 1988-01-28
GB2192882B (en) 1990-05-09
IE60487B1 (en) 1994-07-27
FR2601953B1 (fr) 1990-11-16
DK383587A (da) 1988-01-24
IT8721328A0 (it) 1987-07-16
US4673685A (en) 1987-06-16
YU138187A (en) 1988-12-31
FR2601953A1 (fr) 1988-01-29
PT85381A (en) 1987-08-01
DD263990A5 (de) 1989-01-18
GR871147B (en) 1987-12-04
JPS6335576A (ja) 1988-02-16
BE1000141A3 (fr) 1988-05-03
NO168359B (no) 1991-11-04
PT85381B (pt) 1990-04-30
IT1222054B (it) 1990-08-31
AU599384B2 (en) 1990-07-19
GB2192882A (en) 1988-01-27
PH23711A (en) 1989-09-27
GB8714621D0 (en) 1987-07-29
ATA174887A (de) 1993-06-15
HU198495B (en) 1989-10-30
ZA874255B (en) 1988-02-24
ES2006784A6 (es) 1989-05-16
DK383587D0 (da) 1987-07-22
NZ220677A (en) 1989-12-21
NO873069L (no) 1988-01-25
KR880001660A (ko) 1988-04-25
IL82919A0 (en) 1987-12-20
AT397094B (de) 1994-01-25
JP2557894B2 (ja) 1996-11-27
SE8702936D0 (sv) 1987-07-22
IE871675L (en) 1988-01-23
FI873207A0 (fi) 1987-07-21
YU46321B (sh) 1993-05-28
KR950010596B1 (ko) 1995-09-20
FI873207A (fi) 1988-01-24
CH674010A5 (ja) 1990-04-30
CA1292003C (en) 1991-11-12
DE3724152A1 (de) 1988-02-04
HUT47115A (en) 1989-01-30
NO873069D0 (no) 1987-07-22

Similar Documents

Publication Publication Date Title
US5100889A (en) 7-oxabicycloheptyl substituted heterocyclic amide or ester prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
FR2539129A1 (fr) Analogues amines des prostaglandines 7-oxabicycloheptane-substitues utiles comme medicaments cardio-vasculaires
CA1214178A (en) 7-oxabicycloheptane substituted prostaglandin interphenylene analogs
JPH06211737A (ja) 疾患の治療のための置換シクロヘキサン誘導体
LU85149A1 (fr) Analogues d'amino-prostaglandines substitues par un groupe 7-oxabicycloheptane
FR2574794A1 (fr) Analogues de prostaglandines tetrahydrothienyl-substitues a action cardiovasculaire
LU86949A1 (fr) Acides hydroximiques d'ethers et de thioethers 7-oxabicycloheptane substitues
US5153327A (en) 7-Oxabicycloheptyl substituted heterocyclic amide or ester prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
FR2554818A1 (fr) 7-oxabicycloheptane thio ethers a action therapeutique
FR2611718A1 (fr) Analogues d'amino prostaglandines 7-oxabicycloheptane substitues, a action therapeutique
EP0087655A1 (de) Verfahren zur Herstellung von Acemetacin
FR2581066A1 (fr) 7-oxabicycloheptane ethers, analogues de prostaglandines, a action therapeutique
FR2584074A1 (fr) 5,6-epoxy-7-oxabicycloheptane ethers utiles dans le traitement des thromboses
FR2563522A1 (fr) Analogues de 7 oxabicycloheptane prostaglandines, a action anti-inflammatoire, analgesique et cardiovasculaire
FR2584073A1 (fr) Analogues d'amino-prostaglandines a substituant 5,6-epoxy-7-oxabicycloheptane, utilisables pour le traitement des thromboses
US4806668A (en) Process for the production of 9beta-chloroprostaglandins
FR2580650A1 (fr) Analogues de prostaglandines a substituant 7-oxabicycloheptane, a proprietes therapeutiques
FR2587343A1 (fr) Analogues de 7-oxabicycloheptane oxa prostaglandines a action therapeutique
EP0284202B1 (en) Substituted hydantoin compounds
FR2558836A1 (fr) Analogues d'oxaprostaglandines a substituant 7-oxabicyloheptane, a action therapeutique
FR2580651A1 (fr) Analogues de thio-prostaglandines 7-oxabicycloheptane-substitues, a action therapeutique
FR2598419A1 (fr) Analogues d'amido-carbamoyl prostaglandines 7-oxabicycloheptane substitues, a action therapeutique
BE884145R (fr) Composes indoliques nouveaux
US4044051A (en) 9[2-(1-Alkoxy-ethyl)-5,5-dimethyl-cyclopent-1-en-1-yl]-3,7-dimethyl-nona-2,4,6,8-tetraen acid compounds
FR2604176A1 (fr) Derives fonctionnels du 7-oxabicyclo(2.2.1)heptane a action therapeutique